Logo-apb
Adv Pharm Bull. 2023;13(3): 611-620. doi: 10.34172/apb.2023.057
PMID: 37646060        PMCID: PMC10460813

Research Article

Enhanced Anti-cancer Potency Using a Combination of Oleanolic Acid and Maslinic Acid to Control Treatment Resistance in Breast Cancer

Cigir Biray Avcı 1 * ORCID, Fatma Sogutlu 1, Neslihan Pinar Ozates 1, Behrouz Shademan 1 ORCID, Cumhur Gunduz 1

Cited by CrossRef: 2

1- Wasim M, Bergonzi M. Unlocking the Potential of Oleanolic Acid: Integrating Pharmacological Insights and Advancements in Delivery Systems. Pharmaceutics. 2024;16(6):692 [Crossref]
2- Zhang D, Zhao F, Li J, Guo P, Liu H, Lu T, Li S, Li Z, Li Y. Comprehensive single-cell transcriptomic profiling reveals molecular subtypes and prognostic biomarkers with implications for targeted therapy in esophageal squamous cell carcinoma. Translational Oncology. 2024;44:101948 [Crossref]
3- Tan S, Foo C, Ng F, Tan C, Lim Y. Gene Expression Profiling of Maslinic Acid-treated MCF-7 Breast Cancer Cells Using Nanostring nCounter Pancancer Pathway Panel. Gene. 2025;935:149043 [Crossref]

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by